Boji Medical Technology Co.,Ltd. (300404.SZ)
- Previous Close
7.27 - Open
6.68 - Bid 7.32 x --
- Ask 7.33 x --
- Day's Range
7.10 - 7.33 - 52 Week Range
5.03 - 12.88 - Volume
11,867,411 - Avg. Volume
17,261,226 - Market Cap (intraday)
2.792B - Beta (5Y Monthly) --
- PE Ratio (TTM)
91.38 - EPS (TTM)
0.08 - Earnings Date --
- Forward Dividend & Yield 0.01 (0.14%)
- Ex-Dividend Date Jul 11, 2023
- 1y Target Est
--
Boji Medical Technology Co., Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, product test, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of phased technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co., Ltd. in September 2021. Boji Medical Technology Co., Ltd. was founded in 1998 is headquartered in Guangzhou, China.
www.bojicro.comRelated News
Performance Overview: 300404.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300404.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300404.SZ
Valuation Measures
Market Cap
2.78B
Enterprise Value
2.53B
Trailing P/E
94.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.39
Price/Book (mrq)
2.90
Enterprise Value/Revenue
4.08
Enterprise Value/EBITDA
109.92
Financial Highlights
Profitability and Income Statement
Profit Margin
4.70%
Return on Assets (ttm)
1.77%
Return on Equity (ttm)
3.40%
Revenue (ttm)
619.96M
Net Income Avi to Common (ttm)
29.11M
Diluted EPS (ttm)
0.08
Balance Sheet and Cash Flow
Total Cash (mrq)
368.72M
Total Debt/Equity (mrq)
12.05%
Levered Free Cash Flow (ttm)
-24.52M
Company Insights: 300404.SZ
300404.SZ does not have Company Insights